Ge Jin
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Protective effects of Shenkang injection against diabetic kidney disease via p38 MAPK/NFκB/MCP-1/CCR2 pathway inhibition.
Journal: Frontiers in endocrinology
Published: March 19, 2025
Molecular mechanisms of Potentilla Discolor Bunge in regulating ferroptosis to alleviate DKD via the Nrf2 signaling pathway.
Journal: Journal of ethnopharmacology
Published: March 06, 2025
Exploration of the renoprotective effect of Yi-Shen-Hua-Shi granules on db/db mice and the mechanism of podocyte apoptosis based on the GRP78/CHOP signaling pathway.
Journal: Frontiers in pharmacology
Published: March 02, 2025
Integrated metabolomics and network pharmacology analysis to reveal the mechanisms of Wenshenyang decoction in the treatment of chronic kidney disease.
Journal: Frontiers in pharmacology
Published: September 23, 2024
A randomized, double-blind, placebo-controlled trial of Wenshenyang decoction for the improvement of renal function and kidney-yang deficiency syndrome in patients with CKD.
Journal: Journal of ethnopharmacology
Published: September 06, 2024
Correction to: Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: April 16, 2024
Efficacy and safety of Chinese patent medicine paiteling in condyloma acuminatum: A systematic review and meta-analysis.
Journal: Journal of ethnopharmacology
Published: February 27, 2023
Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: February 15, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026